id: pea_administration_to_toxoplasma_susceptibility
name: Palmitoylethanolamide (PEA) Administration â†’ Toxoplasma gondii Infection Susceptibility
from_node:
  node_id: pea_administration
  node_name: Palmitoylethanolamide (PEA) Administration
to_node:
  node_id: toxoplasma_susceptibility
  node_name: Toxoplasma gondii Infection Susceptibility
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: PEA is administered to mice infected with Toxoplasma gondii'
- 'Step 2: PEA suppresses Th1 cell differentiation and function'
- 'Step 3: Reduced Th1 responses impair pathogen-specific immunity required for T.
  gondii eradication'
- 'Step 4: Impaired immunity leads to enhanced susceptibility to T. gondii infection'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Yasuhiro Soga et al. 2025. "Lipid mediator palmitoylethanolamide
    (PEA) inhibits pathogenic T cell differentiation in vitro and in vivo.." *Biochemical
    and biophysical research communications*. https://doi.org/10.1016/j.bbrc.2024.151085
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.112466'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/biological/pea_administration_to_toxoplasma_susceptibility.yaml
_category: biological
